Related Experiment Videos
Thymectomy for myasthenia gravis: 12-year experience
Rana S Singh1, Sukanta K Behera, Radhakrishnan Saji
1Department of Cardiothoracic and Vascular Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh 160-012, India. medinst@pgi.chd.nic.in
Asian Cardiovascular & Thoracic Annals
|December 19, 2003
Summary
Transsternal radical thymectomy is an effective treatment for myasthenia gravis. This surgery offers sustained improvement, particularly for female patients with moderate to severe symptoms and those with thymic hyperplasia.
Area of Science:
- Neurology
- Surgical Oncology
Background:
- Myasthenia gravis is a neuromuscular disease impacting voluntary muscle movement.
- Thymectomy, the surgical removal of the thymus, is a recognized treatment for myasthenia gravis.
- Optimal patient selection and surgical approach for thymectomy remain subjects of debate.
Purpose of the Study:
- To evaluate the efficacy of transsternal radical thymectomy in treating myasthenia gravis.
- To assess outcomes based on clinical severity and thymic pathology.
Main Methods:
- Retrospective review of 56 patients with myasthenia gravis undergoing transsternal radical thymectomy.
- Patient grouping based on the modified Osserman clinical classification.
- Follow-up duration ranging from 1 month to 12 years.
Main Results:
- Overall, thymectomy demonstrated significant improvement in myasthenia gravis symptoms.
- Improvement rates varied by Osserman group: 25% in Group I, 74% in Group IIA, and 89% in Groups IIB/IIC.
- One hospital death occurred; 53 patients were followed post-surgery.
Conclusions:
- Transsternal radical thymectomy is an effective therapeutic option for myasthenia gravis.
- Sustained symptom improvement is achievable, especially in female patients with moderate to severe disease and those with thymic hyperplasia.